Mirum Pharmaceuticals (NasdaqGM:MIRM) reported positive primary endpoint results from its Phase 2b AZURE-1 study of brelovitug in chronic hepatitis delta virus (HDV). The trial showed robust antiviral ...
Earlier in 2026, Conestoga Capital Advisors highlighted Casella Waste Systems in its first-quarter investor letter, focusing on investor concerns after the company reduced its fiscal 2026 EBITDA ...
Elections, elections, elections, every year. Another election. Go ahead and vote. It’s going to come up to the same darn ...
GE Vernova (GEV) is now central to the AI infrastructure buildout, with energy as a critical bottleneck for data center ...
Semiconductor stocks are surging on AI agent demand and hyperscaler growth. Click for a review of the sector and where it may ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results